There is new hope in the fight against breast cancer.
Scientists have found that silencing the BCL-2 gene in oestrogen receptor positive cancer sufferers makes the cancer more responsive to chemotherapy treatment.
70% of breast cancer sufferers are diagnosed with oestrogen receptor positive cancer.
The research found a diagnostic marker in the blood, potentially making cancer detectable.
Read more at Garvan Institute of Medical Research & Cardiff University